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SUMMARY The delivery of good nutritional care is a fundamental element of the 
management of individuals with Huntington’s disease and all patients with Huntington’s 
disease will, at some time, need dietary intervention because of the sequela of the disease; 
yet there are no European nutritional guidelines. The European Huntington’s Disease 
Network Standards of Care Dietitians Group has brought together expert dietitians from 
across Europe to produce nutritional guidelines to improve the nutritional management of 
individuals with Huntington’s disease. The guidelines were developed to promote optimal 
nutritional screening, assessment and management of individuals throughout all stages of 
the disease, with the aim of improving the standard of nutritional care delivered. Literature 
was systematically searched in an attempt to ensure that the recommendations are based 
on sound evidence and where evidence is lacking, specific guidance is based on consensus 
expert dietetic opinion. The provision of nutritional care varies widely between countries. 
Implementation of these nutritional guidelines across Europe should improve the quality of 
nutritional care delivered to individuals with Huntington’s disease.
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  Good nutritional care is a fundamental element of the management of individuals with 
Huntington’s disease.
  Nutritional assessment and care planning for individuals with Huntington’s disease must take 
account of the stage of the disease and feeding difficulties individuals may experience. 
  Patient’s weight must be monitored regularly and kilocalories should be altered in a way that is 
acceptable to the individual, until an agreed target weight is achieved. 
  Due to the variability in energy requirements and the potential for rapid weight loss, early individual 
assessment and regular reviewing of nutritional care plans are vital.
  Many individuals have very increased energy requirements and it is essential to provide adequate 
macro- and micro-nutrients.
Pr
ac
ti
ce
 P
oi
nt
s
Nutritional management of 
individuals with Huntington’s 
disease: nutritional guidelines
SPECIAL REPORT
Ailsa Brotherton1, Lillian Campos2,3, Arleen Rowell4, Vanessa Zoia5, 
Sheila A Simpson6,7 & Daniela Rae6,7*
part of
For reprint orders, please contact: reprints@futuremedicine.com
Neurodegen. Dis. Manage. (2012) 2(1) future science group34
SPeciAl RePoRt Brotherton, Campos, Rowell, Zoia, Simpson & Rae
Huntington’s disease (HD) is a complex, inherited 
neurodegenerative disorder characterized by 
a progressive movement disorder, cognitive 
impairments, personality and psychiatric 
problems, as well as metabolic changes (Box 1) 
[1]. It is caused by an unstable expansion of a 
CAG sequence within the Huntingtin, known 
as HTT, gene which is located on chromosome 
4 [2]. The protein encoded by the HTT gene 
is important in normal brain and neuronal 
development. The expanded CAG sequence 
leads to the production of an abnormal protein 
that causes brain cell dysfunction and ultimately 
neuronal cell death primarily in the basal ganglia 
but also the thalamus and cerebral cortex [3]. 
This single gene disease follows an autosomal, 
dominant inheritance affecting both men and 
women. Each offspring of an affected parent has 
a 50% chance of inheriting the gene mutation 
and developing the disease. Symptom onset 
usually occurs in mid age but a juvenile onset 
(<20 years of age) and late-age onset are also 
recognized. To some extent the age of onset is 
related to the size of the mutation [4]. 
The prevalence of HD in Europe is estimated 
to be approximately four to ten individuals 
per 100,000. However, recent reports suggest 
that the number of individuals with HD is 
underestimated and that the true prevalence is 
considerably higher [5].
HD is a family disease and most individuals 
have seen one of their parents of other family 
member go through the stages of the disease. 
This makes them very aware of what will or 
might happen to them in the future and has 
a significant influence on their knowledge of 
the disease and decision making, for example 
consenting to enteral tube feeding.
Stages of HD 
There have been several attempts to define the 
stages of progression of HD and symptomatic 
stages are currently based upon the individuals 
total functional capacity score [6]. Current 
research may provide further clarification [7]. For 
these guidelines nutritional recommendations 
have been made in three stages of the disease; 
early, mid and late.
Early-stage disease cannot be defined as the 
time of diagnosis since diagnoses can be made 
at variable times. Most individuals present 
with early neurological features such as subtle 
changes in coordination and mild involuntary 
movements [3]. Psychiatric symptoms and 
cognitive changes often occur prior to the 
development of these motor signs. Hence in early 
stages depression, irritability and difficulty in 
planning, organizing and prioritizing activities 
can be experienced. Although maybe slightly less 
functional, people remain largely independent in 
their daily activities and lives [8]. 
Mid-stage disease would be deemed to have 
been reached when the affected person has to 
cease work, or at least change employment to 
a post that is less challenging [8]. Involuntary 
movements increase and voluntary tasks will 
become more difficult. Executive dysfunction, 
including organizing, reasoned decision 
making, memory diff iculties and reduced 
ability to learn new information make cognitive 
tasks more difficult [3].
Late-stage disease occurs when employment 
becomes impossible, the individual is no longer 
able to live independently [8], self-care ceases 
and cognitive decline is obvious. At this stage 
patients are severely limited in their mobility 
and are often chair or bed bound. Some patients 
maintain the ability to feed themselves to a late 
Box 1. Symptoms of Huntington’s disease.
Motor symptoms
  Chorea
  Dystonia
  Rigidity
  Bradykinesia
  Gait disorder
Cognitive changes
  Difficulties planning and organizing
  Lack of initiation (activities and conversations)
  Perseveration
  Impulsivity
  Irritability and temper outburst
  Perceptual problems
  Unawareness/lack of insight
  Difficulty in new learning
Speech, language and communication problems
  Dysphagia
  Dysarthria
Neuropsychiatric/behavioral symptoms
  Depression
  Obsessive–compulsive disorder
  Irritability
  Apathy
  Anxiety
Other
  Metabolic changes 
  Sleep disturbances
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stage, but swallowing difficulties and involuntary 
movements create increasing diff iculties. 
Cognitive deficits progress to a global dementia. 
Weight loss is a common and recognized 
feature throughout all stages of the disease 
[9–11] and its etiology remains uncertain. Its 
progressive nature is often marked in the later 
stages [9,12,13] of the disease and correlates with 
the CAG repeat number [14]. Evidence, including 
animal studies, suggests that there are several 
possible contributing factors, such as:
  Increased metabolic rate and higher energy 
expenditure perhaps secondary to 
hypothalamic dysfunction [10,15]
  Possible peripheral abnormalities caused by 
the expression of the faulty protein in those 
tissues [12]
  Insufficient intake due to swallowing and 
feeding dif f iculties [16–18] , including 
xerostomia [19]
  Hyperkinetic movement disorder [16]
  Possibly a combination of all the above points
There is great variation in the presence 
of symptoms and the impact of these on an 
individual’s nutritional intake and status. 
Although within this standards of care (SoC) 
document, nutritional care has been subdivided 
into these three stages, according to the usual 
prevalence of the onset of the difficulty, it 
is important to note that individuals may 
experience the difficulties at any time of the 
disease progression.
Role of the European Huntington’s 
Disease Network 
The European Huntington’s Disease Network 
(EHDN) provides a platform for clinicians and 
families to work together to find a cure for HD, 
to coordinate research and in the meantime to 
elicit best practice for the care of individuals with 
HD. Working groups were created to address 
the various themes [101]; one group focusing on 
SoC with specialist subgroups. Care provision 
of HD varies widely between countries. The 
SoC working party has produced a consensus 
view for management of HD, which reflects the 
opinions of experts in their field, and will enable 
others to provide best care for the HD patient 
and their family. 
The EHDN SoC Dietitians Group has 
brought together expert dietitians from across 
Europe to produce nutritional SoC to improve 
the nutritional management of individuals with 
HD. The information contained within this 
guidance is based on the available evidence in the 
nutritional care of individuals with HD, current 
nutritional support guidance and consensus of 
dietetic opinion within the field.
Aims of the nutritional guidelines
The aims of the Nutritional Management of 
Individuals with HD guidelines are to provide 
nutritional guidelines for dietitians to allow for 
optimal nutritional screening, assessment and 
management of individuals throughout all stages 
of HD, with the aim of improving the standard 
of nutritional care delivered and to ensure the 
nutritional management of individuals with 
HD is based on sound evidence and current best 
clinical practice.
  Nutrition guideline development
The delivery of good nutritional care is a 
fundamental element of the management of 
individuals with HD. This guidance attempts to 
bring together the research evidence and expert 
dietetic opinion from across Europe in making 
nutritional recommendations for individuals with 
HD. However, it is important to acknowledge 
the differences in approaches between countries 
and professionals must also take account of their 
national legal requirements, national and local 
policies and procedures and professional codes 
of conduct in the interpretation of this guidance. 
Prior to the development of this guideline the 
literature was systematically searched in an 
attempt to ensure that the recommendations are 
based on sound evidence. However, a number 
of challenges were faced as the published 
literature in the field is limited, especially in 
terms of methods of nutritional screening and 
quantifying nutritional requirements in this 
patient group. The HD nutritional evidence base 
was difficult to interpret for clinical practice for 
the following reasons:
  Few studies provided robust evidence for 
nutritional care in HD
  Studies had small sample sizes
  An extensive range of outcome measures were 
used and these were not directly comparable
  Large gaps in the evidence base 
  Inconsistencies in definitions, for example, 
malnutrition 
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Although the evidence was graded in 
accordance with the SIGN guidelines [102], 
all the specific nutritional recommendations 
contained in this Guideline are based on 
consensus of the expert dietetic opinion of the 
EHDN SoC Dietitians Group, informed by the 
generic nutritional guidelines and established 
clinical practice, because of a lack of evidence 
in the field.
Literature review
A systematic literature search was performed 
electronically using OVID Medline (1988–
2009), OVID Embase (1988–2009) and EBSCO 
Cinahl (1988–2009) to evaluate evidence on 
BMI, weight loss, energy requirements and 
recommendations for nutritional support. A 
search strategy was developed in collaboration 
with the members of the SoC Dietitians Group. 
The literature search was updated during the 
development of the guideline. All relevant 
publications were identified and categorized 
to evidence statements according to SIGN 
methodology [102]. Due to the lack of scientific 
evidence, recommendations were primarily 
formulated based upon clinical experience and 
expert consensus from within the EHDN SoC 
Dietitians Group.
The importance of nutrition in HD
  Key nutritional priorities
Recommendations within published, generic, 
evidence-based nutritional guidelines [102,103] 
are generally applicable in HD. However, 
due to the cognitive, motor, psychiatric and 
communication problems that occur in this 
progressive, degenerative condition additional 
nutritional factors need to be considered. 
Unintended and sometimes rapid weight loss 
is common in people with HD and often occurs 
despite a good appetite [10,20] and a high calorie 
intake [10]. Observation has shown that there can 
be variations in energy requirements throughout 
the course of the disease and between HD 
individuals [10,11] but generally speaking, in the 
premanifest and early stages of HD, patients may 
already have higher energy requirements than the 
normal population [10,20,103]. This may explain 
why their BMI is often lower compared with 
the normal population. A higher bodyweight 
at diagnosis has been associated with a slower 
progression of the disease [21]. The cause of 
increased energy requirements and weight loss 
is not clear and most likely to be multifactorial. 
However, due to the variability in energy 
requirements and the potential for rapid weight 
loss, early individual assessment and regular 
reviewing of nutritional care plans are vital. 
Therefore, the EHDN SoC Dietitians Group 
recommend that, on diagnosis, individuals with 
HD should receive the following dietetic care.
Ensuring adequate nutritional intake 
throughout each stage of the disease
This will require adequate provision of suitable 
foods and fluids, either by the individual or 
their carers. Distinct nutritional challenges 
at each stage of the disease require careful 
dietetic management. Many individuals have 
very increased energy requirements and it is 
essentials to provide adequate macro- and 
micro-nutrients.
When weight loss occurs it can be very 
rapid therefore preventing weight loss and 
maintaining a healthy weight is very important. 
However, this can be difficult to achieve because 
the symptoms of HD also often have a profound 
effect on food intake. 
Protective weight management
There is a high risk of rapid weight loss for many 
individuals but for some, rapid weight gain may 
occur. Studies have found that individuals 
with HD have a lower BMI than controls 
at diagnosis [14,103] and younger age of onset 
usually denotes more aggressive disease and 
possibly an even lower BMI [21]. Rapid weight 
loss can result in loss of muscle mass, weakness, 
apathy, depression, susceptibility to infection 
and compromised chest status.
The risks may change during the progression 
of the condition but both unmanaged weight 
loss or weight gain will be problematic. For this 
reason weight should be carefully managed as 
standard weight management advice may be 
inappropriate for individuals with HD.
Nutrition & function
Poor nutrition is known to impact on function 
in certain neurological populations, for example, 
elderly stroke patients [22,23]. Although there are 
no studies looking at nutrition and function in 
HD per se, due to the physical and cognition 
difficulties poor nutrition has a much greater 
impact on this group. The affected functions 
include strength and muscle mass, levels of 
fatigue (already low in this population group) 
mood (which can already be compromised by 
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the disease itself ) and cognitive function. It 
therefore seems reasonable to ensure optimal 
nutrition so that these factors are not further 
exacerbated by poor diet.
Physical impact on nutritional intake
The main physical problems are difficulties 
with motor coordination and muscle control, 
which may result in uncontrolled movements 
and dif f iculty walking, speaking and 
swallowing. Uncoordinated movements are a 
challenge when handling cutlery and taking 
food to the mouth. Chewing and swallowing 
difficulties arise from uncoordinated movement 
of the face, neck, lips and diaphragm. This can 
make eating and drinking a tiring experience. 
Other common problems are vomiting, reflux 
and regurgitation of food as the systems for 
moving food through the digestive system 
become disrupted.
Cognitive changes affecting food intake
Cognitive changes related to the ability to 
think, impact on problem solving, planning and 
sequencing of ideas. This includes the decisions 
before the food enters the mouth and may lead to 
an inappropriate food choice and/or eating too 
much too quickly. Concentration and memory 
can also be affected. Overall, an individual’s 
awareness and ability to make judgments 
becomes more impaired.
Nutrition & emotion
Mood swings and changes in emotional 
responses are common, all of which can 
adversely affect behaviour. Depression can 
occur and affect the person’s appetite and 
anxiety is common. Anxiety can make 
movements more pronounced and affect the 
swallowing process. Frustration may occur 
when faced with being unable to prepare food 
and eat in the usual way. Many people with 
HD have a great resistance to adaptive changes 
to their lifestyle, which can make accepting 
advice for safer eating or altering the texture 
of food and fluid difficult.
Nutrition & oral health
Particular attention should be given to oral 
health especially where dietary advice increases 
the intake of simple carbohydrates and/
or frequency of meals and snacks as dental 
decay can result. Due to their facial and body 
movements, they are a very difficult group for 
dentists to treat. Oral health will impact on 
the risk of chest infections from aspiration of 
bacteria-laden saliva and will also impact the 
ability to eat and drink if the patient has dental 
problems or pain.
Multidisciplinary approach
Healthcare professionals should ensure that 
all people who need nutrition support receive 
coordinated care from a multidisciplinary team 
(MDT) [103]. It is recognized that members of 
the MDT will vary depending upon the setting 
and local policy, but we stress the importance 
of management of specif ic diff iculties by 
trained therapists, for instance, management 
of swallowing diff iculties by appropriately 
trained speech and language therapists. 
Ideally, the team will also include those who 
have specialist skills in positioning and aides 
for feeding. HD is a neurological condition of 
long duration and as such may have a lengthy 
palliative phase. Diagnosis of HD will have a 
major impact on the quality of life (QoL) of 
the affected individual and their family [24]. A 
multidisciplinary approach is vital to ameliorate 
the problems encountered in caring for this 
population [25].
Behavioral aspects of the disease present 
major nutritional challenges
The disease presents a range of behavioral 
issues as a consequence of psychological and 
cognitive deterioration that can impact on 
nutritional intake. There may be an inability to 
express food preferences or to inform carers of 
discomfort when eating, leading to frustration 
that can present as challenging behavior. This 
can be especially apparent at mealtimes and 
requires skilled feeding techniques and careful 
management by carers. Obsessive behaviors, 
often seen in HD, can impact on food choices 
and dealing with these issues can be very 
challenging. 
Respecting autonomy
Individuals with HD often lack insight into their 
own disease progression. They may not be aware 
of, or are not able to, acknowledge progressive 
symptoms. Individuals will often refuse advice 
and interventions because of a decline in 
cognitive ability, and especially in executive 
function. All nutritional advice provided should 
be set within the context of QoL and patient 
choice.
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Nutritional assessment & evaluation
  Nutritional screening tools
All patients with HD will at some time need 
dietary intervention because of the sequela of the 
disease. On diagnosis they should be screened 
for malnutrition and risk of malnutrition 
by a trained healthcare professional using a 
validated screening tool. Suitable tools include 
the Malnutrition Universal Screening Tool 
(MUST) [26], Mini Nutritional Assessment 
[27] and the Short Nutritional Assessment 
Questionnaire [28]. Screening should be repeated 
according to clinical need and local policy as 
specified in the screening tool adopted. It must 
be stressed that individuals with HD who are 
not underweight, and therefore not identified as 
‘at risk’ on screening, may have an inadequate 
intake of energy and nutrients because of 
factors such as poor food choices or excessive 
alcohol intakes; therefore it is important that 
a diet history is taken regardless of the MUST 
score/screening outcome.
  Nutritional assessment & evaluation
The EHDN Dietitians Group suggest the 
following recommendations for the nutritional 
management of individuals with HD, based on 
a consensus of dietetic expert opinion. NICE [103] 
and ESPEN [102] guidance should be used as a 
guide where appropriate but additional issues 
need to be considered. 
Nutritional support should be considered in 
those who are malnourished, as defined by any 
of the following:
  Unintentional weight loss greater than 10% 
within the last 3–6 months
  A BMI of less than 20 kg/m2 and unintentional 
weight loss greater than 5% within the last 
3–6 months [103]
Table 1. Nutritional challenges and recommended standards of nutritional care for individuals with early-stage disease.
Nutritional challenge/recommended level of 
nutritional care
Rationale for the recommendation
1 Early assessment of nutritional intake and status Severe rapid weight loss is problematic, although not universal
An early assessment of nutritional intake is essential to the delivery of 
effective nutritional care
Early dietetic assessment facilitates delivery of good nutritional care in later 
stages of the disease when the patient becomes unable to communicate 
effectively
2 The baseline assessment should include weight, height, 
BMI, completion of a validated nutritional screening 
tool, calculation of percentage weight loss, record of 
usual weight. If unable to obtain weight, use alternative 
measurements such as mid-arm circumference 
Nutritional assessment should be carried out by a trained health 
professional
The nutritional status of individuals with HD can deteriorate rapidly 
3 Ensure adequate nutrient intake including sufficient 
energy, protein, fluid, electrolytes, minerals, micronutrients 
and fiber needs (NICE, 2006), taking account of any 
increased nutritional needs 
Some individuals have higher energy requirements [11]. Individuals should 
aim for a balanced intake of fat, protein and carbohydrates to provide the 
additional calories to maintain weight
Excessive and frequent intake of simple sugars should be avoided where 
possible as this may impact on dental health
If the dietary assessment indicates an inadequate intake of vitamin and 
minerals, a vitamin and mineral supplement should be considered
4 Consider impact of medication on nutritional intake and 
status
Medications used in the treatment of HD to suppress chorea may affect an 
individual’s weight and food intake. For example, some neuroleptics may 
cause raised triglycerides, raised glucose, dry mouth, constipation, weight 
gain, increased appetite (see medication table in supplementary material 
www.futuremedicine.com/doi/suppl/10.2217/nmt.11.69) 
5 Discuss tube feeding within MDT and identify a member of 
the team to discuss it with the patient focusing on potential 
benefits and burdens. Record the individual’s wishes
Discussing tube feeding in the early stages of the disease before cognitive 
function diminishes and communication becomes difficult. Many 
individuals have witnessed family members experience similar issues and 
are aware of the impact of the advancing disease
Discussions must be patient led; some patients will want to discuss 
feeding fully but others will want to avoid or defer decision making. Group 
discussions or education facilitated by the dietitian may be beneficial
HD: Huntington’s disease; MDT: Multidisciplinary team.
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  A BMI of less than 20 kg/m2 (expert opinion 
is to aim to maintain BMI 23–25)
Nutritional support should also be considered 
for those individuals who struggle to maintain 
their bodyweight and those at risk of malnutri-
tion, defined as individuals who have: 
  A: Eaten little or nothing for more than 5 days 
and/or are likely to eat little or nothing for 5 
days or longer
  B: Food intake below 50–75% in preceding 
week 
  C: A poor absorptive capacity and/or high 
nutrient losses and/or increased nutritional 
needs from causes such as catabolism
Expert dietetic opinion is also that weight loss 
should be considered in individuals with either 
BMI of 27–30 with comorbidities or for those 
with a BMI of over 30 without comorbidities. 
Individuals should only be advised to lose weight 
under the supervision of a dietitian. They will 
require review every 2–4 weeks because of the 
risks of rapid weight loss in some patients.
Optimizing nutritional intake in the 
different stages of HD
  Nutritional management of individuals 
with HD
The nutritional assessment and nutritional care 
planning process should ensure that the total 
nutrient intake of individuals with HD provides 
sufficient energy, protein, f luid, electrolyte, 
mineral, micronutrients and fiber needs [103]. 
The assessment must take account of the possible 
increased nutritional needs, especially kilocalorie 
requirements that can, in some individuals, be 
very high.
Gaba [29] recommended HD specific equations 
for the calculation of energy although there is a 
lack of HD-specific calculations for protein and 
fluid requirements. Nutritional requirements can 
be calculated using a standard equation (such as 
Schofield, Harris Benedict) and the individual’s 
current kilocalorie intake and weight history should 
form an integral part of the baseline nutritional 
assessment to determine estimated requirements.
Frequent monitoring of nutritional intake, 
weight and weight changes is required and 
Table 2. Nutritional challenges and suggested standards of nutritional care for individuals with mid-stage disease.
Nutritional challenges/recommended 
level of nutritional care
Rationale for the recommendation
1 Monitor weight/weight changes should 
be recorded at every clinic visit
If target weight not achieved/weight loss 
>5% re-refer to dietitian 
Nutritional goal in mid stage is often to maintain a healthy weight (BMI: 23–25 is 
recommended by the group), ensuring adequacy of nutritional intake to prevent rapid 
weight loss
NB: caution is required for individuals who are overweight as a weight reducing diet may be 
inappropriate if the person is at risk of future rapid weight loss and feeding difficulties
2 Monitoring nutritional intake 
Discussion of food preferences 
Use of supplements or food fortification
Difficulties with social aspects of eating may impact on nutritional intake
Poor food choices may be important to address in order to motivate behavior change while 
patients are cognitively able to understand the reasons
Particular attention should be paid to any difficulties experienced as a result of advancing 
disease such as problems caused by reduced mobility, dexterity, cognition, swallowing and 
behaviours associated with advancing HD such as food obsessions, food cramming, spillage, 
fear of choking or apathy
3 Food texture modification may be 
indicated 
Texture modified diets will require 
fortification to increase calorific value and 
nutritional supplement may be required 
Referral to the SLT team for assessment is recommended where clinically indicated
Appropriate texture of food and drink is required to minimize the risk of aspiration
4 Altered eating behavioural issues, for 
example, excessive coffee drinking, food 
cramming and fixations
Drug use, excessive alcohol intake or constant smoking may impact on nutritional intake 
Dietary advice and intervention should focus on practical ways to modify intake
recommending alternatives where appropriate, for example, decaffeinated coffee
5 Consider specific problems impacting on 
food intake, for example, sleep difficulties, 
inability to eat normal portions sizes, 
constipation, unawareness of importance 
of nutrition and eating difficulties
Provision of individualized nutritional care plan and implementation of person-centered 
appropriate solution focused strategies to overcome nutritional difficulties
HD: Huntington’s disease.
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adjustments to nutritional intake will need to be 
made to achieve the identified nutritional goals. 
As a baseline for calculating requirements, 
the following NICE guidance [103] is appropriate 
but Dietitians must be aware that some 
individuals will have much higher kilocalorie 
requirements and other nutritional needs. The 
EHDN Dietitians Group make the following 
HD-specific recommendations, incorporating 
NICE guidance:
  25–35 kcal/kg/day total energy (including 
that derived from protein) 
  Ratio of fat and carbohydrate the same as 
normal population
  0.8–1.5 g protein (0.13–0.24 g nitrogen)/kg/
day
  30–35 ml fluid/kg (with allowance for any 
extra requirements, input of fluid from other 
sources and any additional losses) offers a 
baseline for calculating requirements but in 
some individuals fluid requirements may be 
higher so it is important to monitor intake and 
adjust fluid as required, paying particular 
attention to the losses associated with 
difficulties drinking
  Adequate electrolytes, minerals, micronutrients 
(allowing for any pre-existing deficits, excessive 
losses or increased demands) and fiber if 
appropriate. In HD there is no evidence that 
vitamin and mineral requirements are altered 
and caution is appropriate to avoid excess 
intake especially where a range of nutritional 
supplements are recommended to increase 
kilocalorie intake. Dietary advice and/or 
supplements may be required in individuals 
where dietary intake is low, for example due to 
restricted or modified diet where there can be 
significant losses in food processing or where 
there is need especially to ensure adequate 
vitamin C, iron, calcium and vitamin D (in 
the case of vitamin D, important for individuals 
who are confined to indoors)
  Patient’s weight must be monitored regularly 
and kilocalories should be altered in a way that 
is acceptable to the individual, until an agreed 
target weight is achieved
  Dietary advice regarding fiber should be 
individualised advice and based on symptoms
Nutritional assessment and care planning for 
individuals for HD must take account of the 
stage of the disease and the feeding difficulties 
individuals may experience. As with all clinical 
conditions, there are features of the disease that 
may affect the individual’s ability to eat and 
drink, and each stage of the disease presents 
key challenges. The Nutritional challenges 
and recommended level of nutritional care are 
summarised and presented for early-stage disease 
(Table 1), mid-stage disease (Table 2) and end-stage 
disease (Table 3). Table 4 outlines the issues to be 
considered in the decision-making process for 
enteral tube feeding.
Conclusion
Nutritional screening and the delivery of good 
nutritional care are fundamental elements of 
Table 3. Nutritional challenges and suggested standards of nutritional care for individuals with late-stage disease.
Nutritional challenges/recommended level of 
nutritional care
Rationale for the recommendation
1 In addition to the assessment outlined in mid 
stage:
Texture of diet and usual oral intake
Use of supplements or food fortification
Specific difficulties with eating and drinking
Level of independence with eating and drinking
Usual bowel pattern
Ensure good communication between members of the MDT to meet patient’s 
nutritional needs and to have a comprehensive overview of factors impacting on 
ability to eat and drink
Constipation can cause food refusal and/or increase risk of reflux or vomiting
Difficulties with social aspects of eating may impact on nutritional intake. Particular 
attention to any difficulties experienced as a result of advancing disease such as 
difficulties with reduced mobility, dexterity, cognition, swallowing and behaviours 
associated with advancing HD such as food cramming, spillage or apathy 
2 Care settings: on admission:
Commence food and drink record charts
Establish frequency of weighing
Observe the patient eating at a meal time
Establish a suitable target weight
Determine if advance directives exist
Establish a person’s capacity
Identify level of dietetic intervention required
Observation at meals highlights all aspects impacting on a persons ability to eat 
and drink a nutritionally adequate diet 
A target weight ensures the dietitian and nursing team have clear goals regarding 
weight management
HD: Huntington’s disease; MDT: Multidisciplinary team.
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the care of an individual with HD. Other 
factors that impact on food intake should also 
be carefully considered but are outside the 
remit of these nutritional standards. These 
include effective communication strategies, 
appropriate feeding techniques and the 
importance of gathering relevant information 
regarding food preferences in the early stages 
of the disease before cognition becomes 
so impaired that communication becomes 
dif f icult. Feeding and communication 
guidance for dietitians and carers have been 
developed to support these nutritional SoC. 
These address practical management issues, 
recognizing that the best form of support is 
not always straightforward as difficulties often 
arise as a result of the interaction of several 
factors. The guideline has been created for the 
information and support of dietitians caring 
for individuals with HD in hospitals, care 
homes and the community. Some dietitians 
might only care for a small number of clients 
with HD and are unable to develop expertise 
in this area. This framework can be a reference 
point for their practice. For clinicians and 
physicians involved in HD management this 
guide will offer an invaluable insight into the 
role of the dietitian and present assessment and 
referral criteria.
It should be noted that although the guidance 
has been written specifically for patients with 
HD, much of the information may also be 
valuable across other neurodegenerative diseases. 
The EHDN SoC Group plan to audit compliance 
to these SoC across the network and are planning 
a quality improvement program to support units 
to deliver against these standards.
Future perspective
Improving the nutritional care of individuals 
with HD is likely to become much more of a 
priority focus for healthcare systems globally. 
Parenteral and enteral nutrition societies and 
associations are lobbying governments and 
health departments to ensure that nutritional 
care is given the priority focus that it deserves. 
There is an urgent need for further research 
into the nutritional care of patients with HD 
as the role of nutrition in the treatment of the 
disease remains poorly understood. 
Table 4. Decision making for enteral tube feeding.
Recommended level of nutritional care Rationale for the recommendation
1 If the person has an advanced directive stating they do not want a feeding tube, 
this is always upheld
This is legally binding in many European countries
2 Discuss the benefits and burdens of enteral feeding as early as possible and 
record the patient’s wishes, family members should be involved in these 
discussions where appropriate
If the person has capacity to decide whether or not they would want a feeding 
tube, then they should be educated to make an informed choice
Everything that is necessary to facilitate an individual’s understanding and 
retention of the information should be tried. If capacity is uncertain than an 
assessment of capacity should be carried out
Ideally this should not be done at a time of crisis. These discussions should take 
place prior to the need for enteral feeding arising
Family members should to be included in 
discussions (where appropriate) as they will often be 
supporting the patient 
Consent is required for patients able to make 
decisions about their care for any medical 
procedure/treatment
Patients do change their minds so it is good practice 
to routinely ask at intervals if their decision still 
stands
These expressed wishes and views count as 
verbal advance directives and should always be 
documented for future reference (i.e., when the 
patient may no longer be able to communicate)
3 If the patient lacks capacity a multidisciplinary discussion is essential and local 
and national policy must be followed
It is not possible to make a Europe-wide 
recommendation given the differences in legal and 
clinical systems
4 The following should be considered to ensure a best interest decision is made:
Any previous expressed views on polyethylene glycols
Verbal directives to family members/carers
Family views on whether they would want this
Perceived quality of life; this is very subjective
Swallowing difficulty, fear of choking, infection history, weight change and level 
of distress eating causes
Benefit or burden of feeding
In making a best interest decision it is important to 
look at the current situation for the person as it is
It is also relevant to know how they were as a person 
and what they would likely do in this situation if they 
were able to make a decision
This is where it is important to consult staff and 
family that may have had input with the person 
when they expressed such views
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